Found 0 matching trials
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy PHASE1 This study is the first time the new medicine CPV-104 is being tested in pe...
Show More Location
Medizinische Universität Wien
Learn More & Join Trial
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD PHASE1 This was an open label first in human Phase I/II multicentre study of GT005...
Show More Location
Midwest Eye Institute
Learn More & Join Trial
Berinert (C1INH) vs Placebo for DGF/IRI PHASE1 This is a Phase I/II double-blind, randomized, placebo-controlled study ass...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
Serologically Active, Clinically Stable Systemic Lupus Erythematosus PHASE2 The first part of this study will use the database of a large, ongoing NIH-...
Show More Location
North Shore-Long Island Jewish Health System
Learn More & Join Trial
A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants PHASE1 The primary objective of this study is to perform mass balance following a ...
Show More Location
Covance Clinical Research Unit, Inc.
Learn More & Join Trial
Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 PHASE3 We propose a study on Ataxia with oculomotor apraxia type 1 (AOA1) in which...
Show More Learn More & Join Trial
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) PHASE3 This study aims to evaluate the efficacy and safety of crovalimab in adult ...
Show More Status
Active Not Recruiting
Location
Univ of CA San Francisco
Learn More & Join Trial
Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants PHASE1 This study is designed to evaluate the safety and tolerability, pharmacokin...
Show More Location
Clinical Trial Site
Learn More & Join Trial
A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH PHASE1 This study will be the initial exploration of pegcetacoplan in patients wit...
Show More Location
University of Southern California Norris Comprehensive Cancer Center
Learn More & Join Trial
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma PHASE1 This is a first in human, phase 1, multicenter, open-label study to determi...
Show More Learn More & Join Trial